Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Metastatic Uveal Melanoma
NCT01377025Phase 2Unknown
- Start
- Jun 2011
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in Uveal melanoma (UM). Status: unknown.
02
Drugs
sorafenib
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT01377025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377025.